Association of plasma fibrinogen, C-reactive protein and G-455>A polymorphism with early atherosclerosis in the VITA Project cohort

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 329-335

  Tosetto, Alberto ^a   Prati, Patrizio ^b   Baracchini, Claudio ^a   Manara, Renzo ^a   Rodeghiero, Francesco ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b Gervasutta Hospital   (Italy)

Author keywords

C reactive protein; Carotid atherosclerosis; Epidemiology; Fibrinogen; Ultrasonography

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; COHORT ANALYSIS; COMMON CAROTID ARTERY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; ITALY; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 79851485055     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-08-0522     Document Type: Article

References (36)

1. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly. Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990; 265: 6389-6393.
2. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc 1998; 279: 1477-1482. (Pubitemid 28228207)
3. Danesh J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. J Am Med Assoc 2005; 294: 1799-1809. (Pubitemid 41434626)
4. Smith GD, Harbord R, Milton J, et al. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies. Arterioscler Thromb Vasc Biol 2005; 25: 2228-2233. (Pubitemid 41416326)
5. Verschuur M, de Jong M, Felida L, et al. A hepatocyte nuclear factor-3 site in the fibrinogen beta promoter is important for interleukin 6-induced expression, and its activity is influenced by the adjacent -148C/T polymorphism. J Biol Chem 2005; 280: 16763-16771. (Pubitemid 41389134)
6. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005; 3: 1618-1627. (Pubitemid 41716547)
7. Rodeghiero F, Tosetto A. The VITA Project: Population-based distribution of protein C, antithrombin III, heparin cofactor II and plasminogen. Relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996; 76: 226-233.
8. Rodeghiero F, Tosetto A. The epidemiology of inherited thrombophilia: the VITA Project. Thromb Haemost 1997; 78: 636-640. (Pubitemid 27289318)
9. Tosetto A, Prati P, Baracchini C, et al. Age-adjusted reference limits for carotid intima-media thickness as better indicator of vascular risk: population-based estimates from the VITA project. J Thromb Haemost 2005; 3: 1224-1230. (Pubitemid 41725246)
10. Ingram G. The determination of plasma fibrinogen by the clot-weight method. Biochem J 1952; 51: 583-585.
11. Humphries SE, Ye S, Talmud P, et al. European Atherosclerosis Research Study: genotype at the fibrinogen locus (G-455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment. Arterioscler Thromb Vasc Biol 1995; 15: 96-104.
12. Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. PWS-Kent Publishing Company, Boston 1988.
13. Hosmer DW, Lemeshow S. Applied logistic regression. John Wiley & Sons, New York 1989.
14. Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133-1163. (Pubitemid 351395448)
15. StataCorp. Stata Statistical Software: Release 11.0. Stata Corporation, College Station, TX, USA 2010.
16. Meade TW. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. J Thromb Haemost 2005; 3: 632-634. (Pubitemid 41647870)
17. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505. (Pubitemid 14059351)
18. Meade TW, Brozovic MM, Chakrabarti RR, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-537. (Pubitemid 16054632)
19. Yarnell JW, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white clood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative Heart Disease Studies. Circulation 1991; 83: 836-844.
20. Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997; 146: 483-494.
21. Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999; 30: 841-850. (Pubitemid 29156378)
22. Prati P, Tosetto A, Vanuzzo D, et al. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke 2008; 39: 2470-2476.
23. Zureik M, Touboul PJ, Bonithon-Kopp C, et al. Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study. Stroke 1999; 30: 550-555. (Pubitemid 29115391)
24. van der Meer I, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004; 109: 1089-1094. (Pubitemid 38332611)
25. O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 1996; 27: 224-231.
26. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. New Engl J Med 1999; 340: 14-22. (Pubitemid 29024679)
27. Tsivgoulis G, Vemmos K, Papamichael C, et al. Common carotid artery intimamedia thickness and the risk of stroke recurrence. Stroke 2006; 37: 1913-1916. (Pubitemid 44297751)
28. Lee AJ, Mowbray PI, Lowe GD, et al. Blood viscosity and elevated carotid intimamedia thickness in men and women: the Edinburgh Artery Study. Circulation 1998; 97: 1467-1473. (Pubitemid 28191302)
29. Branson HE, Katz J, Marble R, et al. Inherited protein C deficiency and coumarinresponsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2: 1165-1168. (Pubitemid 14243933)
30. Grebe M, Luu B, Sedding D, et al. Fibrinogen Promotes Early Atherosclerotic Changes of the Carotid Artery in Young, Healthy Adults. J Atheroscler Thromb 2010; 17: 1003-1008.
31. Fibrinogen Studies Collaboration. Plasma fibrinogen and the risk of major cardiovascular diseases and non-vascular mortality: meta-analysis of individual data for 151,649 adults in 31 prospective studies. J Am Med Assoc 2005; 294: 1799-1809.
32. Hamsten A, Mannila MN, Silveira A. Quest for genes regulating plasma fibrinogen concentration: still a long way to go. Arterioscler Thromb Vasc Biol 2005; 25: 1100-1101. (Pubitemid 40776594)
33. Soria JM, Almasy L, Souto JC, et al. A genome search for genetic determinants that influence plasma fibrinogen levels. Arterioscler Thromb Vasc Biol 2005; 25: 1287-1292. (Pubitemid 40776623)
34. Green D, Foiles N, Chan C, et al. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis 2009; 202: 623-631.
35. Woodward M, Rumley A, Welsh P, et al. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease. J Thromb Haemost 2007; 5: 1795-1800. (Pubitemid 47288932)
36. Prahl U, Wikstrand J, Bergstrom G, et al. Slightly Elevated High-Sensitivity C-Reactive Protein (hsCRP) Concentrations Are Associated With Carotid Atherosclerosis in Women With Varying Degrees of Glucose Tolerance. Angiology 2010; 61: 793-801.